References
- Weaver DF, Pohlmann-Eden B. Pharmacoresistant epilepsy: unmet needs in solving the puzzle(s). Epilepsia. 2013;54(Suppl 2):80–85.
- Pati S, Alexopoulos AV. Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies. Cleve Clin J Med. 2010;77:457–467.
- Sisodiya SM. Genetics of drug resistance. Epilepsia. 2005;46:33–38.
- Clynen E, Swijsen A, Raijmakers M, et al. Neuropeptides as targets for the development of anticonvulsant drugs. Mol Neurobiol. 2014;50:626–646.
- Kovac S, Walker MC. Neuropeptides in epilepsy. Neuropeptides. 2013;47:467–475.
- Dobolyi A, Kékesi K, Juhász G, et al. Receptors of peptides as therapeutic targets in epilepsy research. Current Medicinal Chemistry. 2014;21:764–787.
- Dag E, Aydin S, Ozkan Y, et al. Alteration in chromogranin A, obestatin and total ghrelin levels of saliva and serum in epilepsy cases. Peptides. 2010;31:932–937.
- Aydin S, Dag E, Ozkan Y, et al. Time-dependent changes in the serum levels of prolactin, nesfatin-1 and ghrelin as a marker of epileptic attacks young male patients. Peptides. 2011;32:1276–1280.
- Ataie Z, Golzar MG, Babri S, et al. Does ghrelin level change after epileptic seizure in rats? Seizure. 2011;20:347–349.
- Aydin S, Dag E, Ozkan Y, et al. Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem. 2009;328:49–56.
- Palasz A, Krzystanek M, Worthington J, et al. Nesfatin-1, a unique regulatory neuropeptide of the brain. Neuropeptides. 2012;46:105–112.
- Liu Z, Wang F, Li ZZ, et al. Expression of neuropeptides ghrelin and Nesfatin-1 in kainic acid kindling rats. Zhonghua Yi Xue Za Zhi. 2011;91:496–500.
- Obay BD, Taşdemir E, Tümer C, et al. Dose dependent effects of ghrelin on pentylenetetrazole-induced oxidative stress in a rat seizure model. Peptides. 2008;29:448–455.
- Obay BD, Tasdemir E, Tumer C, et al. Antiepileptic effects of ghrelin on pentylenetetrazole-induced seizures in rats. Peptides. 2007;28:1214–1219.
- Portelli J. Michotte Y and Smolders I. Ghrelin: an emerging new anticonvulsant neuropeptide. Epilepsia. 2012;53:585–595.
- Bostrom P, Wu J, Jedrychowski MP, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463–468.
- Cooke A, Gomez YH, Mutter A, et al. Irisin, a novel hormone and exercise intensity in young healthy subjects. Can J Cardiol. 2013;29:S340–S341.
- Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98:E769–778.
- Piya MK, Harte AL, Sivakumar K, et al. The identification of irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers, and gestational diabetes. Am J Physiol Endocrinol Metab. 2014;306:E512–518.
- Erden Y, Tekin S, Sandal S, et al. Effects of central irisin administration on the uncoupling proteins in rat brain. Neurosci Lett. 2016;618:6–13.
- Liu X, Wu Y, Huang Q, et al. Grouping pentylenetetrazol-induced epileptic rats according to memory impairment and MicroRNA expression profiles in the hippocampus. PloS One. 2015;10:e0126123.
- Avoli M. The epileptic hippocampus revisited: back to the future. Epilepsy Currents. 2007;7:116–118.
- Zhu X, Dong J, Shen K, et al. NMDA receptor NR2B subunits contribute to PTZ-kindling-induced hippocampal astrocytosis and oxidative stress. Brain Research Bulletin. 2015;114:70–78.
- Wrann CD, White JP, Salogiannnis J, et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metabolism. 2013;18:649–659.
- Ilhan A, Iraz M, Kamisli S, et al. Pentylenetetrazol-induced kindling seizure attenuated by Ginkgo biloba extract (EGb 761) in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1504–1510.
- Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor Seizure. Electroencephalogr Clin Neurophysiol. 1972;32:281–294.
- Prodam F, Bellone S, Casara G, et al. Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid. Epilepsia. 2010;51:312–315.
- Berilgen MS, Mungen B, Ustundag B, et al. Serum ghrelin levels are enhanced in patients with epilepsy. Seizure. 2006;15:106–111.
- Erken HA, Koc ER, Erken G, et al. Proconvulsant Effect of NUCB2/Nesfatin-1. Int J Pept Res Ther. 2015;21:29–38.
- Arida RM, Cavalheiro EA, Da Silva AC, et al. Physical activity and epilepsy: proven and predicted benefits. Sports Med. 2008;38:607–615.
- Zhang W, Chang L, Zhang C, et al. Irisin: a myokine with locomotor activity. Neurosci Lett. 2015;595:7–11.
- Brailoiu E, Deliu E, Sporici RA, et al. Irisin evokes bradycardia by activating cardiac-projecting neurons of nucleus ambiguus. Physiol Rep. 2015;3:1–8.